SCHEMBL18876355

SCHEMBL18876355

CCCCCc1cc(-c2cccs2)cs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 7/20 0.39
GAA P10253 2/20 0.39
SREBF2 Q12772 1/20 0.39
PRMT6 Q96LA8 1/20 0.38
LTA4H P09960 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 2/20 0.37
KCNH2 Q12809 1/20 0.37
HSD17B10 Q99714 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 2/20 0.36
ALOX15 P16050 2/20 0.36
GAPDH P04406 1/20 0.36
NR4A1 P22736 1/20 0.36
APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18876270 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EGAASREBF2PRMT6
SCHEMBL7261765 0.82 TAAR1 (0.53) ALDH1A1KDM4EPRMT6LTA4HNPC1
SCHEMBL18309102 0.81 ALDH1A1 (0.38) ALDH1A1KDM4EGAAHPGDTP53
SCHEMBL7266725 0.79 DPP4 (0.41) ALDH1A1KDM4EPRMT6LTA4HNPC1
SCHEMBL21391973 0.78 CYP11B1 (0.42) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL30179464 0.78 CYP11B1 (0.42) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL15791270 0.76 ALDH1A1 (0.37) ALDH1A1GAAHPGDSMN1; SMN2MEN1
SCHEMBL14089649 0.76 DPP4 (0.44) ALDH1A1KDM4EGAAPRMT6LTA4H
SCHEMBL18876263 0.76 SREBF2 (0.37) ALDH1A1KDM4EGAASREBF2PRMT6
SCHEMBL4949049 0.76 DPP4 (0.44) ALDH1A1KDM4EGAAPRMT6LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170335191-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-23 US disclosed
US-20170306234-A1 LIQUID CRYSTAL COMPOSITION, METHOD OF PRODUCING THE SAME, AND RETARDATION FILM CONSTITUTED FROM THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-26 US disclosed
US-20170283700-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-05 US disclosed
US-20170145312-A1 LIQUID CRYSTAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170335191-A1 LIQUID CRYSTAL COMPOSITION RCC1, CCDC47, ACIN1 ALDH1A1 4362/4885KDM4E 2427/4885GAA 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.